BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34509691)

  • 1. A generic sample preparation method for the multiplex analysis of seven therapeutic monoclonal antibodies in human plasma or serum with liquid chromatography-tandem mass spectrometry.
    Amrani ME; Gerencser L; Huitema ADR; Hack CE; van Luin M; van der Elst KCM
    J Chromatogr A; 2021 Oct; 1655():462489. PubMed ID: 34509691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry.
    El Amrani M; Szanto CL; Hack CE; Huitema ADR; Nierkens S; van Maarseveen EM
    Anal Bioanal Chem; 2018 Sep; 410(23):5849-5858. PubMed ID: 29938370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method.
    El Amrani M; van den Broek MP; Göbel C; van Maarseveen EM
    J Chromatogr A; 2016 Jul; 1454():42-8. PubMed ID: 27264745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Quantification of Free Adalimumab and Infliximab in Human Plasma Using a Target-Based Sample Purification and Liquid Chromatography-Tandem Mass Spectrometry.
    El Amrani M; Bosman SM; Egas AC; Hack CE; Huitema ADR; van Maarseveen EM
    Ther Drug Monit; 2019 Oct; 41(5):640-647. PubMed ID: 31584927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
    Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
    Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
    Willeman T; Jourdil JF; Gautier-Veyret E; Bonaz B; Stanke-Labesque F
    Anal Chim Acta; 2019 Aug; 1067():63-70. PubMed ID: 31047150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
    Jourdil JF; Némoz B; Gautier-Veyret E; Romero C; Stanke-Labesque F
    Ther Drug Monit; 2018 Aug; 40(4):417-424. PubMed ID: 29608486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
    Jourdil JF; Lebert D; Gautier-Veyret E; Lemaitre F; Bonaz B; Picard G; Tonini J; Stanke-Labesque F
    Anal Bioanal Chem; 2017 Feb; 409(5):1195-1205. PubMed ID: 27826630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
    Li W; Lin H; Fu Y; Flarakos J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle-up quantification of therapeutic monoclonal antibodies in human plasma with two dimensional liquid chromatography high resolution mass spectrometry: Adalimumab as a proof of principle.
    Amrani ME; van der Elst KCM; Huitema ADR; van Luin M
    J Chromatogr A; 2022 Feb; 1665():462840. PubMed ID: 35121176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS.
    Chiu HH; Liao HW; Shao YY; Lu YS; Lin CH; Tsai IL; Kuo CH
    Anal Chim Acta; 2018 Aug; 1019():93-102. PubMed ID: 29625688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of simple and rapid method for Emicizumab quantification by LC-MS/MS in human plasma.
    Josset L; Hodin S; Delinger S; Marin C; Dargaud Y; Delavenne X
    J Pharm Biomed Anal; 2023 Jan; 223():115163. PubMed ID: 36410129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.
    Heudi O; Barteau S; Zimmer D; Schmidt J; Bill K; Lehmann N; Bauer C; Kretz O
    Anal Chem; 2008 Jun; 80(11):4200-7. PubMed ID: 18465883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Cetuximab in Plasma by Liquid Chromatography-High-Resolution Mass Spectrometry Orbitrap With a Stable Labeled 13C,15N-Cetuximab Internal Standard.
    Millet A; Lebert D; Picard G; You B; Ceruse P; Guitton J
    Ther Drug Monit; 2019 Aug; 41(4):467-475. PubMed ID: 31306393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches.
    Legeron R; Xuereb F; Chaignepain S; Gadeau AP; Claverol S; Dupuy JW; Djabarouti S; Couffinhal T; Schmitter JM; Breilh D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():43-53. PubMed ID: 29111437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion.
    Chiu HH; Tsai YJ; Lo C; Lin CH; Tsai IL; Kuo CH
    Anal Chim Acta; 2022 Feb; 1193():339319. PubMed ID: 35058007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipients.
    Truffot A; Jourdil JF; Veyret-Gautier E; Noble J; Jouve T; Malvezzi P; Rostaing L; Stanke-Labesque F
    Clin Biochem; 2023 Mar; 113():17-20. PubMed ID: 36586569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A: A method validation study.
    Donners AAMT; Gerencsér L; van der Elst KCM; Egberts TCG; de Maat MPM; Huisman A; Urbanus RT; El Amrani M
    Res Pract Thromb Haemost; 2022 May; 6(4):e12725. PubMed ID: 35702589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study.
    Marin C; Khoudour N; Millet A; Lebert D; Bros P; Thomas F; Ternant D; Lacarelle B; Guitton J; Ciccolini J; Blanchet B
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully validated LC-MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum.
    Jiang H; Zeng J; Titsch C; Voronin K; Akinsanya B; Luo L; Shen H; Desai DD; Allentoff A; Aubry AF; Desilva BS; Arnold ME
    Anal Chem; 2013 Oct; 85(20):9859-67. PubMed ID: 24024648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.